NO20000107D0 - Ny blanding - Google Patents
Ny blandingInfo
- Publication number
- NO20000107D0 NO20000107D0 NO20000107A NO20000107A NO20000107D0 NO 20000107 D0 NO20000107 D0 NO 20000107D0 NO 20000107 A NO20000107 A NO 20000107A NO 20000107 A NO20000107 A NO 20000107A NO 20000107 D0 NO20000107 D0 NO 20000107D0
- Authority
- NO
- Norway
- Prior art keywords
- new mixture
- mixture
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
PCT/EP1998/004971 WO1999002142A2 (en) | 1997-07-11 | 1998-07-07 | Novel composition comprising an ssri and a beta-blocker |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000107L NO20000107L (no) | 2000-01-10 |
NO20000107D0 true NO20000107D0 (no) | 2000-01-10 |
Family
ID=10815744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000107A NO20000107D0 (no) | 1997-07-11 | 2000-01-10 | Ny blanding |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0996466A2 (no) |
JP (1) | JP2002508003A (no) |
KR (1) | KR20010021644A (no) |
CN (1) | CN1262627A (no) |
AP (1) | AP2000001728A0 (no) |
AR (1) | AR016128A1 (no) |
AU (1) | AU9340198A (no) |
BG (1) | BG104119A (no) |
BR (1) | BR9810996A (no) |
CA (1) | CA2295822A1 (no) |
CO (1) | CO4950552A1 (no) |
DZ (1) | DZ2556A1 (no) |
EA (1) | EA200000112A1 (no) |
GB (1) | GB9714675D0 (no) |
HU (1) | HUP0003074A3 (no) |
ID (1) | ID24191A (no) |
IL (1) | IL133869A0 (no) |
MA (1) | MA24604A1 (no) |
NO (1) | NO20000107D0 (no) |
OA (1) | OA11276A (no) |
PE (1) | PE99699A1 (no) |
PL (1) | PL338017A1 (no) |
SK (1) | SK72000A3 (no) |
TR (1) | TR200000074T2 (no) |
WO (1) | WO1999002142A2 (no) |
ZA (1) | ZA986138B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE457169T1 (de) | 1998-10-15 | 2010-02-15 | Imp Innovations Ltd | Verbindungen für die behandlung von gewichtsverlust |
PT1126826E (pt) | 1998-11-02 | 2008-11-25 | Elan Pharma Int Ltd | Composição de metilfenidato de libertação modificada multiparticulada |
KR101476574B1 (ko) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
MXPA03003895A (es) | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada. |
WO2006030306A2 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
DE69607904T2 (de) * | 1995-08-16 | 2000-10-05 | Lilly Co Eli | Potenzierung von Serotonin-Wirkstoffresponz |
EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107D0/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR9810996A (pt) | 2000-08-08 |
PL338017A1 (en) | 2000-09-25 |
IL133869A0 (en) | 2001-04-30 |
CA2295822A1 (en) | 1999-01-21 |
SK72000A3 (en) | 2000-12-11 |
OA11276A (en) | 2003-07-31 |
CO4950552A1 (es) | 2000-09-01 |
HUP0003074A2 (hu) | 2001-01-29 |
HUP0003074A3 (en) | 2001-12-28 |
PE99699A1 (es) | 1999-12-21 |
AU9340198A (en) | 1999-02-08 |
ID24191A (id) | 2000-07-13 |
AR016128A1 (es) | 2001-06-20 |
ZA986138B (en) | 2000-01-10 |
JP2002508003A (ja) | 2002-03-12 |
DZ2556A1 (fr) | 2003-02-15 |
WO1999002142A2 (en) | 1999-01-21 |
MA24604A1 (fr) | 1999-04-01 |
CN1262627A (zh) | 2000-08-09 |
GB9714675D0 (en) | 1997-09-17 |
NO20000107L (no) | 2000-01-10 |
KR20010021644A (ko) | 2001-03-15 |
AP2000001728A0 (en) | 2000-03-31 |
EP0996466A2 (en) | 2000-05-03 |
TR200000074T2 (tr) | 2000-05-22 |
WO1999002142A3 (en) | 1999-04-15 |
EA200000112A1 (ru) | 2000-10-30 |
BG104119A (en) | 2000-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961588L (no) | Ny blanding | |
NO951704L (no) | Vann-avstötende blanding | |
NO993785D0 (no) | Blanding hvor den elektrostatiske virkningen svinner | |
NO994003L (no) | Farmasoytisk blanding | |
DK0900021T3 (da) | Fungicid blanding | |
NO20001830D0 (no) | Ny kombinasjon | |
NO20001014L (no) | Dermatologisk blanding | |
DE69817830D1 (de) | Kieselsaürehaltige schwefel-vulkanisierbare kautschukmischung | |
ATE446389T1 (de) | Enzymgemisch | |
NO982732D0 (no) | Ny fremgangsmÕte | |
NO992427D0 (no) | Farmas°ytisk blanding | |
NO985864D0 (no) | Antiviral blanding | |
NO20004491D0 (no) | Blanding | |
PT1036083E (pt) | Novos 9a-azalidos | |
NO993298D0 (no) | Ny fremgangsmÕte | |
DK0797386T3 (da) | Fungicid blanding | |
DK0986304T3 (da) | Fungicid blanding | |
NO995796L (no) | Ny fremgangsmåte | |
NO20000107D0 (no) | Ny blanding | |
DK1139758T3 (da) | Fungicid blanding | |
DK0983266T3 (da) | Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider | |
FI974212A (fi) | Eristin | |
NO20003834L (no) | Blanding | |
ATE227077T1 (de) | Fungizide mischung | |
FI98053B (fi) | Sekoitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |